Vaginal estrogen supplementation during Depo-Provera initiation: A randomized controlled trial

Contraception

Volumn 82, Issue 3, 2010, Pages 250-255

  Dempsey, Angela ^a   Roca, Claudia ^b   Westhoff, Carolyn ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Columbia University ^*  (United States)

Author keywords

Contraceptive continuation; Depot medroxyprogesterone acetate; Estradiol vaginal ring; Irregular bleeding

Indexed keywords

ESTRADIOL; MEDROXYPROGESTERONE ACETATE;

ACNE; ADULT; ARTICLE; BREAST TENDERNESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MOOD DISORDER; NAUSEA; PATIENT COMPLIANCE; PATIENT SATISFACTION; PROSPECTIVE STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SPOTTING; SUPPLEMENTATION; VAGINA BLEEDING; VAGINA DISCHARGE; VAGINA RING; WEIGHT CHANGE;

ADMINISTRATION, INTRAVAGINAL; ADULT; CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE; DELAYED-ACTION PREPARATIONS; ESTROGENS; FEMALE; HEMORRHAGE; HUMANS; LOGISTIC MODELS; MEDROXYPROGESTERONE ACETATE; PATIENT SATISFACTION; PROSPECTIVE STUDIES;

EID: 77955564827     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2010.04.003     Document Type: Article

References (21)

1. Mosher W.D., Martinez G.M., and Chandra A. Use of contraception and use of family planning services in the United States: 1982-2002 Adv Data 2004 1 36
2. Hubacher D., Goco N., and Gonzalez B. Factors affecting continuation rates of DMPA Contraception 60 1999 345 351
3. Lim S.W., Rieder J., and Coupey S.M. Depot medroxyprogesterone acetate use in inner-city, minority adolescents: continuation rates and characteristics of long-term users Arch Pediatr Adolesc Med 153 1999 1068 1072
4. Paul C., Skegg D.C., and Williams S. Depot medroxyprogesterone acetate. Patterns of use and reasons for discontinuation Contraception 56 1997 209 214
5. Polaneczky M., and Liblanc M. Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents J Adolesc Health 23 1998 81 88 (Pubitemid 28371283)
6. Sangi-Haghpeykar H., Poindexter A.N. III, and Bateman L. Experiences of injectable contraceptive users in an urban setting Obstet Gynecol 88 1996 227 233
7. Rickert V.I., Tiezzi L., and Lipshutz J. Depo Now: preventing unintended pregnancies among adolescents and young adults [see comment] J Adolesc Health 40 2007 22 28
8. Harel Z., Biro F.M., and Kollar L.M. Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant J Adolesc Health 19 1996 118 123
9. Apelo R., Bergstein N., and Souza J.C. Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids: norethisterone oenanthate and medroxyprogesterone acetate Contraception 17 1978 395 406
10. Said S., Omar K., and Koetsawang S. A multicentered phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg: II. The comparison of bleeding patterns. World Health Organization Task Force on Long-Acting Systemic Agents for Fertility Regulation. Special Programme of Research, Development and Research Training in Human Reproduction Contraception 35 1987 591 610
11. Krikun G., Sakkas D., and Schatz F. Endometrial angiopoietin expression and modulation by thrombin and steroid hormones: a mechanism for abnormal angiogenesis following long-term progestin-only contraception Am J Pathol 164 2004 2101 2107
12. Krikun G., Schatz F., and Lockwood C.J. Endometrial angiogenesis: from physiology to pathology Ann N Y Acad Sci 1034 2004 27 35
13. Lockwood C.J., Krikun G., and Rahman M. The role of decidualization in regulating endometrial hemostasis during the menstrual cycle, gestation, and in pathological states Semin Thromb Hemost 33 2007 111 117
14. Lockwood C.J., Schatz F., and Krikun G. Angiogenic factors and the endometrium following long-term progestin-only contraception Histol Histopathol 19 2004 167 172
15. Schatz F., Krikun G., and Baergen R.N. Intercellular adhesion molecule-1 expression in human endometrium: implications for long-term progestin-only contraception Reprod Biol Endocrinol 4 2006 1 7
16. Alvarez-Sanchez F., Brache V., and Thevenin F. Hormonal treatment for bleeding irregularities in Norplant implant users Am J Obstet Gynecol 174 1996 919 922
17. Said S., Sadek W., and Rocca M. Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. World Health Organization, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulation Hum Reprod 11 Suppl 2 1996 1 13
18. Goldberg A.B., Cardenas L.H., and Hubbard A.E. Post-abortion depot medroxyprogesterone acetate continuation rates: a randomized trial of cyclic estradiol Contraception 66 2002 215 220
19. Femring (estradiol acetate vaginal ring) Prescribing Information 2005 Warner Chilcott UK Limited, Larne Northern Ireland, UK
20. Belsey E.M., Machin D., and d'Arcangues C. The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction Contraception 34 1986 253 260
21. Mishell D.R. Jr., Guillebaud J., and Westhoff C. Recommendations for standardization of data collection and analysis of bleeding in combined hormone contraceptive trials Contraception 75 2007 11 15